DRMA ($DRMA) Insider Trading & Smart Money Activity

DRMA · Biotechnology · Latest filing Jun 16, 2026

$DRMA has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($26.18), net -$26.18.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 1
Net insider $ (12 mo): -$26.18
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

DRMA insider buying and selling by quarter

Quarter	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0 / 0	0 / 0
Q2 2026	2 · $26.18	0 / 0	0 / 0
Q3 2026	0	0 / 0	0 / 0
Q4 2026	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All DRMA insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 16, 2026	Insider	Kathleen Scott	Sell (Open-market sale)	11 sh	$13.09						—
Jun 16, 2026	Insider	Kathleen Scott	Sell (Open-market sale)	11 sh	$13.09						—

1W / 1M / 6M = how DRMA moved from the trade or filing date.

Insider trading in DRMA: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Kathleen Scott		2	-$26.18		Jun 16, 2026

Frequently asked questions

Are DRMA insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $26.18, a net -$26.18.

What is the latest insider trade in DRMA?

Kathleen Scott filed a sell (open-market sale) of 11 sh worth $13.09 on Jun 16, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text